4.8 Article

Taurine up-regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma

期刊

HEPATOLOGY
卷 67, 期 1, 页码 188-203

出版社

WILEY
DOI: 10.1002/hep.29462

关键词

-

资金

  1. Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPD1D0381, CMRPD1D0382, CMRPD1D0383, NMRPD1D1011, NMRPD1D1012, NMRPD1D1013, NMRPD1D1021, NMRPD1D1022, NMRPD1D1023]
  2. Ministry of Science and Technology (MOST) of the Republic of China [MOST 103-2320-B-182-017-MY3, 103-2320-B-182-018-MY3, MOST 104-2811-B-182-011, 105-2811-B-182-011]

向作者/读者索取更多资源

Cancer cells display altered glucose metabolism characterized by a preference for aerobic glycolysis. The aerobic glycolytic phenotype of hepatocellular carcinoma (HCC) is often correlated with tumor progression and poorer clinical outcomes. However, the issue of whether glycolytic metabolism influences metastasis in HCC remains unclear. In the current study, we showed that knockdown of taurine up-regulated gene 1 (TUG1) induces marked inhibition of cell migration, invasion, and glycolysis through suppression of microRNA (miR)-455-3p. MiR-455-3p, which is transcriptionally repressed by p21, directly targets the 3 untranslated region of adenosine monophosphate-activated protein kinase subunit beta 2 (AMPK2). The TUG1/miR-455-3p/AMPK2 axis regulates cell growth, metastasis, and glycolysis through regulation of hexokinase 2 (HK2). TUG1 is clearly associated with HK2 overexpression and unfavorable prognosis in HCC patients. Conclusion: Our data collectively highlight that novel regulatory associations among TUG1, miR-455-3p, AMPK2, and HK2 are an important determinant of glycolytic metabolism and metastasis in HCC cells and support the potential utility of targeting TUG1/HK2 as a therapeutic strategy for HCC. (Hepatology 2018;67:188-203)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据